Seven Fleet Capital Management LP 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Seven Fleet Capital Management LP disclosed 96 US equity positions worth $605.9m in its Q2 2026 13F filing. The largest position was CGON at 22.1% of the reported book, followed by TNGX and RVMD. Against the Q1 2026 filing, it opened 10 new positions, added to 34 and reduced 6 among the top 50 holdings.
What did Seven Fleet Capital Management LP own in Q2 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | CGON CG ONCOLOGY INC | Healthcare | 22.1% | $134.0m | 1,886,236 | 2390% | added |
| 2 | TNGX TANGO THERAPEUTICS INC | Healthcare | 15.8% | $95.7m | 3,228,144 | 543% | added |
| 3 | RVMD REVOLUTION MEDICINES INC | Healthcare | 7.5% | $45.3m | 242,029 | 200% | added |
| 4 | PHVS PHARVARIS N V | Healthcare | 4.4% | $26.8m | 774,501 | 348% | added |
| 5 | LQDA LIQUIDIA CORPORATION | Healthcare | 3.4% | $20.5m | 256,603 | 37% | added |
| 6 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 3.1% | $18.5m | 365,386 | 123% | added |
| 7 | ABVX ABIVAX SA | Healthcare | 2.4% | $14.8m | 111,334 | 159% | added |
| 8 | AVTX AVALO THERAPEUTICS INC | Healthcare | 2.4% | $14.2m | 770,765 | 260% | added |
| 9 | MIRM MIRUM PHARMACEUTICALS INC | Healthcare | 2.1% | $12.9m | 110,393 | – | new |
| 10 | ASMB ASSEMBLY BIOSCIENCES INC | Healthcare | 2.0% | $11.9m | 433,147 | 671% | added |
| 11 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 1.8% | $10.7m | 4,347,826 | 47% | added |
| 12 | CYTK CYTOKINETICS INC | Healthcare | 1.7% | $10.1m | 118,240 | 93% | added |
| 13 | TSHA TAYSHA GENE THERAPIES INC | Healthcare | 1.6% | $9.9m | 1,504,400 | 140% | added |
| 14 | MANE VERADERMICS INC | Healthcare | 1.6% | $9.8m | 80,000 | – | new |
| 15 | AVBP ARRIVENT BIOPHARMA INC | Healthcare | 1.4% | $8.6m | 246,606 | 391% | added |
| 16 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 1.3% | $7.9m | 117,067 | 491% | added |
| 17 | XNCR XENCOR INC | Healthcare | 1.3% | $7.8m | 368,305 | 360% | added |
| 18 | ROIV ROIVANT SCIENCES LTD | Healthcare | 1.3% | $7.8m | 220,126 | 72% | added |
| 19 | DMRA DAMORA THERAPEUTICS INC | Healthcare | 1.2% | $7.4m | 284,430 | 181% | added |
| 20 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 1.2% | $7.1m | 28,826 | 105% | added |
| 21 | DFTX DEFINIUM THERAPEUTICS INC | Healthcare | 1.2% | $7.0m | 148,647 | 49% | added |
| 22 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 1.0% | $6.3m | 64,723 | 19% | added |
| 23 | COGT COGENT BIOSCIENCES INC | Healthcare | 0.9% | $5.7m | 147,510 | -1% | reduced |
| 24 | ERAS ERASCA INC | Healthcare | 0.9% | $5.6m | 308,007 | 38% | added |
| 25 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 0.9% | $5.6m | 45,400 | 1035% | added |
| 26 | NERV MINERVA NEUROSCIENCES INC | 0.9% | $5.6m | 1,001,373 | 303% | added | |
| 27 | EDIT EDITAS MEDICINE INC | Healthcare | 0.7% | $4.3m | 1,330,500 | – | new |
| 28 | CTMX CYTOMX THERAPEUTICS INC. | Healthcare | 0.7% | $4.1m | 1,085,398 | 192% | added |
| 29 | EPRX EUPRAXIA PHARMACEUTICALS INC | 0.7% | $4.0m | 610,785 | 41% | added | |
| 30 | STRO SUTRO BIOPHARMA INC | Healthcare | 0.6% | $3.8m | 159,118 | – | new |
| 31 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.6% | $3.3m | 178,222 | -31% | reduced |
| 32 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 0.5% | $3.2m | 86,664 | 196% | added |
| 33 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.5% | $3.2m | 11,869 | – | new |
| 34 | SGMT SAGIMET BIOSCIENCES INC | Healthcare | 0.5% | $3.1m | 403,545 | – | new |
| 35 | ZLAB ZAI LAB LTD | Healthcare | 0.5% | $2.9m | 136,016 | 75% | added |
| 36 | SABS SAB BIOTHERAPEUTICS INC | 0.5% | $2.9m | 736,077 | 636% | added | |
| 37 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 0.4% | $2.7m | 4,973 | 47% | added |
| 38 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 0.4% | $2.5m | 7,540 | – | new |
| 39 | RLMD RELMADA THERAPEUTICS INC | Healthcare | 0.4% | $2.4m | 348,265 | – | new |
| 40 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 0.3% | $2.1m | 56,900 | -73% | reduced |
| 41 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.3% | $2.1m | 33,300 | – | new |
| 42 | SVRA SAVARA INC | Healthcare | 0.3% | $1.9m | 309,103 | 5% | added |
| 43 | CCCC C4 THERAPEUTICS INC | Healthcare | 0.3% | $1.8m | 381,169 | 568% | added |
| 44 | PCVX VAXCYTE INC | Healthcare | 0.3% | $1.8m | 29,800 | -73% | reduced |
| 45 | CELC CELCUITY INC | Healthcare | 0.3% | $1.7m | 16,252 | 171% | added |
| 46 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 0.3% | $1.6m | 77,930 | – | new |
| 47 | ZNTL ZENTALIS PHARMACEUTICALS INC | Healthcare | 0.2% | $1.5m | 317,600 | 189% | added |
| 48 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 0.2% | $1.4m | 26,800 | 198% | added |
| 49 | LONA LEONABIO INC | 0.2% | $1.4m | 154,153 | -6% | reduced | |
| 50 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 0.2% | $1.4m | 37,865 | -56% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.